Bioequivalence Study of Clopidogrel 75 mg in Two Tablet Formulations Relative to Reference Tablet in Healthy Subjects

Clinical trial NCT02502812 · COMPLETED

Trial details

NCT number: NCT02502812
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Cardiovascular Disease

Start date: 2015-09-04
Primary completion: 2015-09-24
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.